Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · IEX Real-Time Price · USD
3.030
-0.690 (-18.55%)
Jul 22, 2024, 10:06 AM EDT - Market open
RGC Employees
Regencell Bioscience Holdings had 12 employees as of June 30, 2023. The number of employees decreased by 1 or -7.69% compared to the previous year.
Employees
12
Change (1Y)
-1
Growth (1Y)
-7.69%
Revenue / Employee
n/a
Profits / Employee
-$489,261
Market Cap
39.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 12 | -1 | -7.69% |
| Jun 30, 2022 | 13 | -1 | -7.14% |
| Jun 30, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Qilian International Holding Group | 298 |
| Fortress Biotech | 186 |
| Carisma Therapeutics | 107 |
| BioXcel Therapeutics | 74 |
| Lucid Diagnostics | 70 |
| Envoy Medical | 34 |
| Matinas BioPharma Holdings | 32 |
| CalciMedica | 12 |
RGC News
- 2 years ago - Regencell Bioscience's Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial - Business Wire
- 2 years ago - Sector Rotation And 9 Stocks To Watch During A Recession - Benzinga
- 2 years ago - Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period - Business Wire
- 2 years ago - Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO - Business Wire
- 2 years ago - Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network - Accesswire
- 2 years ago - Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms - Benzinga
- 2 years ago - Regencell Bioscience's Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial - Business Wire
- 2 years ago - Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors - Business Wire